How It Works

Based on our proprietary Seed Amplification Assay (SAA), the SYNTapⓇ Biomarker Test mimics and accelerates the process of Synuclein misfolding and accumulating. In addition, this assay reduces the brain’s 20-50 year cycle to 100 hours in the lab. The SYNTap Biomarker Test helps doctors diagnose Parkinson’s Disease (PD), Lewy Body Dementia (LBD), and other Synuclein-related conditions.

Six Steps For the SYNTap Test

Amprion Six Step Process

We’re People-Focused

YOU are the reason we work hard to solve age-old problems. You are the center of our work. In communities, we thrive.

We’re Science-Forward

We’re people of a breakthrough mindset. Our mission is to advance science. We strive to change the world one molecule at a time.

We're Community Oriented

We’ve put together various treatment center directories to help people dealing with Alzheimer’s, Lewy Body Dementia, and Parkinson’s. 

Why Should You Trust Amprion?

We are proud to receive the FDA’s Breakthrough Device Designation award for detecting misfolded Synuclein associated with Parkinson’s disease.

Amprion pioneers the research on misfolded proteins and have published peer-reviewed articles in many scientific journals.

We’re also proud to count the NIH, Alzheimer’s Drug Discovery Fund (ADDF), and the Michael J Fox Foundation among our most supportive research partners.

Benefit of CSF testing

CSF testing offers the highest accuracy and reliability. 

CSF vs. Blood

Benefit of CSF testing

CSF testing offers the highest accuracy and reliability. 

amprion logo quote solid blue
You lose nothing when fighting for a cause ... In my mind, the losers are those who don't have a cause they care about.
Muhammad Ali
Muhammad Ali
Heavyweight Boxing Champion
Scroll to Top